Mary Agnes Carey has covered health reform and federal health policy for more than 15 years as an editor at CQ HealthBeat
, as Capitol Hill Bureau Chief for Congressional Quarterly
and at Dow Jones Newswires. A frequent radio and television commentator, recently featured on the Nightly Business Report, the PBS NewsHour and on NPR affiliates nationwide, Mary Agnes has a thorough understanding of both the policy and politics of health reform. She worked for newspapers in Connecticut and Pennsylvania, and has a master's degree in journalism from Columbia University. | Contact: MaryAgnesC@kff.org | @MaryAgnesCarey
Health and Human Services Secretary Kathleen Sebelius said Tuesday that “within a couple months we will have a very robust call center operation” to answer consumers’ questions about the new health overhaul law.
Government officials, physicians and nonprofit groups are trying to respond to requests for information as Americans struggle to understand the complexities of the new health law.
In a test of the Obama administration's ability to smoothly implement the sweeping health care overhaul law, officials at the Department of Health and Human Services have just 90 days to launch an insurance program for people who can't get private coverage because of health problems.
Lawmakers agreed in health bill to increase Medicare payments by $800 million to hospitals and doctors in a handful of states.
Senate debate over the health reform reconciliation bill could start as early as Tuesday and conclude before Congress adjourns for a two-week recess at the end of the week.
In their push to pass a sweeping health care overhaul this weekend, House Democrats unveiled a package of legislative fixes to lure undecided or opposed members of their party to the “yes” category.
As health care legislation falters, health groups worry that proposed spending cutbacks might be used to narrow the budget gap, not expand coverage.
The president has long championed comparative effectiveness research, saying it would provide crucial information to determine which regimen or drug should be used. But critics fear that could lead to an effort to cut costs and restrict patients' choices.
The Democrats' health overhaul legislation is in trouble for many reasons, including key policy decisions that led many Americans to wonder whether they would wind up worse off.
The final decision on who should supervise health exchanges is critical to health plan choices available to consumers, the cost of the premiums and the clout regulators may have.